128 related articles for article (PubMed ID: 10206071)
21. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
[TBL] [Abstract][Full Text] [Related]
24. Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides.
Wang S; Allen N; Vickers TA; Revenko AS; Sun H; Liang XH; Crooke ST
Nucleic Acids Res; 2018 Apr; 46(7):3579-3594. PubMed ID: 29514240
[TBL] [Abstract][Full Text] [Related]
25. A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.
Coulson JM; Poyner DR; Chantry A; Irwin WJ; Akhtar S
Mol Pharmacol; 1996 Aug; 50(2):314-25. PubMed ID: 8700139
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.
Watson PH; Pon RT; Shiu RP
Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215
[TBL] [Abstract][Full Text] [Related]
27. Bioimpacts of anti epidermal growth factor receptor antisense complexed with polyamidoamine dendrimers in human lung epithelial adenocarcinoma cells.
Nakhlband A; Barar J; Bidmeshkipour A; Heidari HR; Omidi Y
J Biomed Nanotechnol; 2010 Aug; 6(4):360-9. PubMed ID: 21323109
[TBL] [Abstract][Full Text] [Related]
28. Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.
Saijo Y; Uchiyama B; Abe T; Satoh K; Nukiwa T
Jpn J Cancer Res; 1997 Jan; 88(1):26-33. PubMed ID: 9045892
[TBL] [Abstract][Full Text] [Related]
29. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of interleukin-1 type I receptor expression in human cell-lines by an antisense phosphorothioate oligodeoxynucleotide.
Miraglia L; Geiger T; Bennett CF; Dean NM
Int J Immunopharmacol; 1996 Apr; 18(4):227-40. PubMed ID: 8894802
[TBL] [Abstract][Full Text] [Related]
31. Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells.
Alper O; De Santis ML; Stromberg K; Hacker NF; Cho-Chung YS; Salomon DS
Int J Cancer; 2000 Nov; 88(4):566-74. PubMed ID: 11058872
[TBL] [Abstract][Full Text] [Related]
32. Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo.
Nielsen TO; Sorensen S; Dagnæs-Hansen F; Kjems J; Sorensen BS
Br J Cancer; 2013 Jun; 108(11):2291-8. PubMed ID: 23695025
[TBL] [Abstract][Full Text] [Related]
33. Expression of antisense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon cancer cells.
Chakrabarty S; Rajagopal S; Huang S
Clin Exp Metastasis; 1995 May; 13(3):191-5. PubMed ID: 7750206
[TBL] [Abstract][Full Text] [Related]
34. Bispecific antisense oligonucleotides have activity comparable to monospecifics in inhibiting expression of BCL-2 in LNCaP cells.
Rubenstein M; Guinan P
In Vivo; 2010; 24(4):489-93. PubMed ID: 20668314
[TBL] [Abstract][Full Text] [Related]
35. Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides.
Stewart AJ; Canitrot Y; Baracchini E; Dean NM; Deeley RG; Cole SP
Biochem Pharmacol; 1996 Feb; 51(4):461-9. PubMed ID: 8619891
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the epidermal growth factor receptor gene expression in a morphological variant isolated from an epidermal growth factor receptor-deficient small cell lung carcinoma cell line.
Gamou S; Shimosato Y; Shimizu N
Cell Growth Differ; 1990 Aug; 1(8):351-9. PubMed ID: 1980602
[TBL] [Abstract][Full Text] [Related]
37. Oligonucleotide treatment of ras-induced tumors in nude mice.
Wickstrom E
Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
[TBL] [Abstract][Full Text] [Related]
38. Antisense inhibition of epidermal growth factor receptor decreases expression of human surfactant protein A.
Klein JM; McCarthy TA; Dagle JM; Snyder JM
Am J Respir Cell Mol Biol; 2000 Jun; 22(6):676-84. PubMed ID: 10837364
[TBL] [Abstract][Full Text] [Related]
39. Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer.
Zhang P; Zhang P; Zhou M; Jiang H; Zhang H; Shi B; Pan X; Gao H; Sun H; Li Z
Carcinogenesis; 2013 Nov; 34(11):2639-46. PubMed ID: 23764753
[TBL] [Abstract][Full Text] [Related]
40. Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells.
deFazio A; Chiew YE; McEvoy M; Watts CK; Sutherland RL
Cell Growth Differ; 1997 Aug; 8(8):903-11. PubMed ID: 9269899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]